443 related articles for article (PubMed ID: 7631589)
21. [Corticosteroid therapy].
Reinhart WH
Praxis (Bern 1994); 2005 Feb; 94(7):239-43. PubMed ID: 15773140
[TBL] [Abstract][Full Text] [Related]
22. Potential adverse effects of the inhaled corticosteroids.
Kelly HW; Nelson HS
J Allergy Clin Immunol; 2003 Sep; 112(3):469-78; quiz 479. PubMed ID: 13679801
[TBL] [Abstract][Full Text] [Related]
23. Problems when withdrawing corticosteroids.
Drug Ther Bull; 1987 Sep; 25(19):73-5. PubMed ID: 3665733
[No Abstract] [Full Text] [Related]
24. [Problems raised by corticoid therapy in children].
Mathieu H
Rev Prat; 1975 Mar; 25(15):1151-8. PubMed ID: 1172288
[No Abstract] [Full Text] [Related]
25. Complications of corticosteroid and immunosuppressive drugs.
Rubin B; Palestine AG
Int Ophthalmol Clin; 1989; 29(3):159-71. PubMed ID: 2526794
[No Abstract] [Full Text] [Related]
26. ACTH vs. corticosteroids in therapy-utilize one and-or the other?
Brandon ML
Ann Allergy; 1972 May; 30(5):262-75. PubMed ID: 4336845
[No Abstract] [Full Text] [Related]
27. [The secondary effects of inhaled steroids in asthma. New prospects].
González Pérez-Yarza E; de Frutos Martínez C; Mintegui Aranburu J
Arch Bronconeumol; 1999 May; 35 Suppl 3():15-21. PubMed ID: 10410219
[No Abstract] [Full Text] [Related]
28. Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statement.
Mooney E; Rademaker M; Dailey R; Daniel BS; Drummond C; Fischer G; Foster R; Grills C; Halbert A; Hill S; King E; Leins E; Morgan V; Phillips RJ; Relic J; Rodrigues M; Scardamaglia L; Smith S; Su J; Wargon O; Orchard D
Australas J Dermatol; 2015 Nov; 56(4):241-51. PubMed ID: 25752907
[TBL] [Abstract][Full Text] [Related]
29. [Immediate and late harmful manifestations and results of parenteral and local corticotherapy in chronic rheumatic patients].
Marin D
Minerva Med; 1971 Feb; 62(16):758-63. PubMed ID: 4251441
[No Abstract] [Full Text] [Related]
30. Corticosteroids in Lupus.
Kasturi S; Sammaritano LR
Rheum Dis Clin North Am; 2016 Feb; 42(1):47-62, viii. PubMed ID: 26611550
[TBL] [Abstract][Full Text] [Related]
31. The efficacy and safety of low-dose corticosteroids for rheumatoid arthritis.
Caldwell JR; Furst DE
Semin Arthritis Rheum; 1991 Aug; 21(1):1-11. PubMed ID: 1948096
[TBL] [Abstract][Full Text] [Related]
32. [Systemic effects of inhaled corticosteroids. Various pending questions].
Ferreira MB; Pedro E; Barbosa MA; Carlos AG
Acta Med Port; 1997 Nov; 10(11):819-24. PubMed ID: 9549114
[TBL] [Abstract][Full Text] [Related]
33. [Corticosteroid treatment and adrenal regulatory system].
Goischke HK
ZFA (Stuttgart); 1978 Aug; 54(22):1129-33. PubMed ID: 685408
[No Abstract] [Full Text] [Related]
34. [Prolonged therapeutic use of corticosteroids. Indications and risks].
Bondy PK
Recenti Prog Med; 1980 Nov; 69(5):531-50. PubMed ID: 7008122
[No Abstract] [Full Text] [Related]
35. Inhaled corticosteroids: benefits and risks.
Robinson DS; Geddes DM
J Asthma; 1996; 33(1):5-16. PubMed ID: 8621371
[No Abstract] [Full Text] [Related]
36. Topical steroids and hypothalamo-pituitary-adrenal suppression: a review.
Bartley PC
Australas J Dermatol; 1978 Dec; 19(3):109-13. PubMed ID: 371599
[No Abstract] [Full Text] [Related]
37. Corticosteroids in the treatment of rheumatologic diseases.
Morand E
Curr Opin Rheumatol; 1997 May; 9(3):200-5. PubMed ID: 9204254
[TBL] [Abstract][Full Text] [Related]
38. Using corticosteroids.
Pittman JG
Am Fam Physician; 1971 May; 3(5):96-100. PubMed ID: 4325070
[No Abstract] [Full Text] [Related]
39. [Ocular changes in rheumatic disease].
Guffanti A
Minerva Med; 1978 Sep; 69(46):3134-7. PubMed ID: 309569
[No Abstract] [Full Text] [Related]
40. Iatrogenic morbidity accompanying suppression of temporal arteritis by adrenal corticosteroids.
Rubinow A; Brandt KD; Cohen AS; Sack B
Ann Ophthalmol; 1984 Mar; 16(3):258-60, 262, 264-5. PubMed ID: 6712068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
